EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
Moderna (NASDAQ:MRNA) Earns "Sector Perform" Rating from Royal Bank of Canada
Rhumbline Advisers Sells 20,902 Shares of Moderna, Inc. (NASDAQ:MRNA)
Moderna (NASDAQ:MRNA) Price Target Lowered to $78.00 at UBS Group
Moderna (MRNA) Expected to Announce Earnings on Thursday
Moderna (NASDAQ:MRNA) Stock Price Up 8.8% - Time to Buy?
Moderna's (MRNA) "Sector Perform" Rating Reiterated at Royal Bank of Canada
Moderna: A Generational Opportunity for Investors in 2025 | Investing.com
Why Moderna (MRNA) Went Up on Tuesday?
MRNA: A Once-in-a-Generation Opportunity for Investors in 2025
Moderna (NASDAQ:MRNA) Stock Rating Lowered by Barclays
Moderna price target lowered to $78 from $96 at UBS | Markets Insider
Top Defense Stocks To Research - February 18th
Stock Traders Purchase Large Volume of Moderna Call Options (NASDAQ:MRNA)
Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook
Early notable gainers among liquid option names on February 18th
Morgan Stanley Keeps Their Hold Rating on Moderna (MRNA) | Markets Insider
Moderna downgraded to Equal Weight from Overweight at Barclays | Markets Insider
RBC Capital Sticks to Its Hold Rating for Moderna (MRNA) | Markets Insider
'Medical coercion': U.S. Dept. of Veterans Affairs still insists on COVID vax mandate
Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release? - February 18, 2025 - Zacks.com
Moderna price target raised to $39 from $38 at Morgan Stanley | Markets Insider
Bernstein Reaffirms Their Hold Rating on Moderna (MRNA) | Markets Insider
Moderna, Inc. (NASDAQ:MRNA) Q4 2024 Earnings Call Transcript
Baillie Gifford & Co. Has $1.62 Billion Stake in Moderna, Inc. (NASDAQ:MRNA)
Intrinsic Value Partners LLC Decreases Holdings in Moderna, Inc. (NASDAQ:MRNA)
AustralianSuper Pty Ltd Purchases 2,077 Shares of Moderna, Inc. (NASDAQ:MRNA)
Best Pharmaceutical Stocks To Watch Now - February 14th
Moderna (NASDAQ:MRNA) Shares Gap Down - What's Next?
Banque Pictet & Cie SA Sells 22,425 Shares of Moderna, Inc. (NASDAQ:MRNA)
Vontobel Holding Ltd. Has $10.74 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)
Compagnie Lombard Odier SCmA Sells 8,018 Shares of Moderna, Inc. (NASDAQ:MRNA)
Rep. Julie Johnson Unloads Shares of Moderna, Inc. (NASDAQ:MRNA)
Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by Vontobel Holding Ltd.
Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts
Q4 2024 Moderna Inc Earnings Call Transcript
Health Care Down as Moderna Shares Slide - Health Care Roundup | Morningstar
Moderna price target lowered to $25 from $35 at Wolfe Research | Markets Insider
Moderna says norovirus vaccine trial on FDA clinical hold | Markets Insider
Best Biotech Stocks To Keep An Eye On - February 14th
Moderna Earnings: Maintaining Our $102 Fair Value Estimate as Long-Term Pipeline and Strategy Intact | Morningstar
Moderna's Shot Sales, Canceled Contract Lead to Another Loss
Moderna trading resumes | Markets Insider
Moderna trading halted, volatility trading pause | Markets Insider
Hedge fund giant Bridgewater made a new bet on Tesla. They may have gotten a bargain. | Morningstar
News Highlights: Top Company News of the Day - Friday at 9 AM ET | Morningstar
Moderna (MRNA) Reports Wider-Than-Expected Losses Amid Decreased Vaccine Demand
Moderna is counting on its product pipeline to resuscitate its ailing stock | Morningstar
News Highlights: Top Company News of the Day - Friday at 7 AM ET | Morningstar
Moderna looks to pipeline to restore battered stock after quarterly loss | Morningstar
Moderna (MRNA) Q4 earnings 2024
Moderna's wider-than-expected loss and soft guidance weigh on battered stock | Morningstar
Moderna posts bigger loss than expected as vaccine maker scales down manufacturing
Moderna beats on revenue but loses more than expected as it scales down manufacturing
Moderna Stock Down 5% As Q4 EPS Misses Estimates, But Revenues Top
Guillain-Barré case puts Moderna norovirus vax trial on hold | BioWorld
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline - February 14, 2025 - Zacks.com
Senate votes to confirm Robert Kennedy as head of HHS | Markets Insider
Moderna fined for trying to lure children into Covid vaccine trials with teddy bears
Sumitomo Mitsui DS Asset Management Company Ltd Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA)
Moderna (MRNA) Projected to Post Quarterly Earnings on Friday
Bank of America Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock Price
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Sumitomo Mitsui Trust Group Inc.
Moderna (NASDAQ:MRNA) Hits New 1-Year Low - Here's Why
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - February 12, 2025 - Zacks.com
Bank of America Cuts Moderna (NASDAQ:MRNA) Price Target to $34.00
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2024 Earnings Call Transcript
Moderna price target lowered to $34 from $41 at BofA
Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Insights Into Moderna (MRNA) Q4: Wall Street Projections for Key Metrics - February 11, 2025 - Zacks.com
Biogen Gears Up to Report Q4 Earnings: What's in the Cards? - February 11, 2025 - Zacks.com
Activest Wealth Management Sells 386 Shares of Moderna, Inc. (NASDAQ:MRNA)
Why Moderna Inc. (MRNA) Crashed Last Week
Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast? - February 10, 2025 - Zacks.com
Quattro Financial Advisors LLC Acquires 22,500 Shares of Moderna, Inc. (NASDAQ:MRNA)
Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates? - February 3, 2025 - Zacks.com
